Signaling Pathways
| Product Name | CAS No. | Specification | Application | Registration |
| MMAF Hydrochloride | 1415246-68-2 | 99+% | ||
| Maytansinol | 57103-68-1 | 99+% | ||
| Monomethyl Auristatin F (MMAF) | 745017-94-1 | 99+% | ||
| Maytansinoid DM4 | 799840-96-3 | 98+% | ||
| Monomethyl Auristatin E (MMAE) | 474645-27-7 | 99+% | ||
| Alprostadil (Prostaglandin E1) | 745-65-3 | 98+% | ||
| Lubiprostone | 136790-76-6 | 98+% | ||
| Travoprost | 157283-68-6 | 99+% | ||
| Bimatoprost | 155206-00-1 | 99+% | ||
| Latanoprost | 130209-82-4 | 99+% | ||
| Pomalidomide | 19171-19-8 | 98+% | ||
| Docetaxel Trihydrate | 148408-66-6 | 99+% | ||
| Docetaxel | 114977-28-5 | 98+% | ||
| Cladribine | 4291-63-8 | 98+% | ||
| Cytarabine | 147-94-4 | 99+% |
Products
- All
- Pharmaceutical Intermediates
- Active Pharmaceutical Ingredients
- Drug Impurities & Metabolites
- Novel Life Science Reagents
- Signaling Pathways
- Inhibitory Antibodies
- Bioactive Small Molecules
- Screening Compounds
- Stable Isotope Labelled Compounds
- COVID-19 Related Inhibitors
- Amino Acids & Vitamins
- Natural Products
- Health & Nutritional Ingredients
- Pharmaceutical Excipients
- Specialty Chemicals & Building Blocks
Custom Synthesis-High Value-Added Advanced Pharmaceutical Intermediates
E-Mail: sales (at)Chemleader.com.cn
E-Mail: sales (at)Chemleader.com.cn